More Images
In the U.K., Prime Minister Boris Johnson announced a 4-week delay to the next step in easing England's lockdown from next Monday to July 19. His plans were blown off course by the rise in Delta variant cases, now found to be rising "exponentially."

Data from Scotland published in The Lancet found the Delta variant approximately doubles the risk of hospitalization compared with the Alpha variant.

Oxford University's RECOVERY trial demonstrated that Regeneron's investigational antibody combination reduces the risk of death when given to patients hospitalized with severe COVID-19 who have not mounted a natural antibody response of their own.

Head over to Medscape to read the full story.